104.97
price down icon1.31%   -1.39
after-market Dopo l'orario di chiusura: 105.03 0.06 +0.06%
loading
Precedente Chiudi:
$106.36
Aprire:
$106.65
Volume 24 ore:
431.37K
Relative Volume:
0.68
Capitalizzazione di mercato:
$5.17B
Reddito:
$338.46M
Utile/perdita netta:
$-310.96M
Rapporto P/E:
-16.08
EPS:
-6.53
Flusso di cassa netto:
$-132.82M
1 W Prestazione:
-6.48%
1M Prestazione:
+0.68%
6M Prestazione:
+1.80%
1 anno Prestazione:
+23.16%
Intervallo 1D:
Value
$104.47
$106.99
Intervallo di 1 settimana:
Value
$102.54
$113.98
Portata 52W:
Value
$72.21
$139.13

Axsome Therapeutics Inc Stock (AXSM) Company Profile

Name
Nome
Axsome Therapeutics Inc
Name
Telefono
(212) 332-3241
Name
Indirizzo
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Name
Dipendente
589
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-18
Name
Ultimi documenti SEC
Name
AXSM's Discussions on Twitter

Confronta AXSM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AXSM
Axsome Therapeutics Inc
104.97 5.24B 338.46M -310.96M -132.82M -6.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-03 Ripresa Morgan Stanley Overweight
2025-06-03 Iniziato Oppenheimer Outperform
2025-04-07 Iniziato Jefferies Buy
2025-02-11 Iniziato Deutsche Bank Buy
2024-12-31 Reiterato Mizuho Outperform
2024-09-03 Iniziato Wells Fargo Overweight
2024-08-06 Aggiornamento BofA Securities Neutral → Buy
2024-07-22 Iniziato Needham Buy
2024-04-29 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2024-03-19 Iniziato Robert W. Baird Outperform
2024-02-06 Iniziato UBS Buy
2024-01-25 Iniziato RBC Capital Mkts Outperform
2023-12-13 Iniziato Citigroup Buy
2023-08-08 Aggiornamento BofA Securities Underperform → Neutral
2023-01-05 Iniziato Piper Sandler Neutral
2022-11-01 Iniziato Loop Capital Buy
2022-09-07 Ripresa Mizuho Buy
2021-08-10 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-06-10 Iniziato Berenberg Buy
2021-01-08 Iniziato Jefferies Buy
2020-12-16 Iniziato Mizuho Buy
2020-09-29 Iniziato BofA Securities Underperform
2020-09-10 Iniziato Morgan Stanley Overweight
2020-04-28 Reiterato H.C. Wainwright Buy
2020-04-14 Iniziato Cowen Outperform
2019-12-30 Reiterato H.C. Wainwright Buy
2019-12-17 Reiterato H.C. Wainwright Buy
2019-12-16 Reiterato Guggenheim Buy
2019-10-16 Iniziato Guggenheim Buy
2019-09-18 Iniziato William Blair Outperform
2019-05-28 Iniziato SunTrust Buy
2019-05-23 Reiterato H.C. Wainwright Buy
2019-04-08 Iniziato SVB Leerink Outperform
2019-03-15 Reiterato H.C. Wainwright Buy
2016-10-03 Ripresa Brean Capital Buy
2015-12-15 Iniziato Cantor Fitzgerald Buy
2015-12-14 Iniziato Ladenburg Thalmann Buy
Mostra tutto

Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie

pulisher
Jul 24, 2025

How To Trade (AXSM) - news.stocktradersdaily.com

Jul 24, 2025
pulisher
Jul 24, 2025

Why Axsome Therapeutics Inc. stock is on top investor watchlistsTremendous wealth creation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

How high can Axsome Therapeutics Inc. stock price go in 2025Consistently profitable trades - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Is This Stock a Buy After Soaring by 20% in 1 Day? - AOL.com

Jul 24, 2025
pulisher
Jul 24, 2025

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Legato Capital Management LLC Buys New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Is Axsome Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Axsome Therapeutics (NASDAQ:AXSM) Trading Down 5.6%Here's What Happened - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Leerink Partners Keeps Bullish Stance on Axsome Therapeutics with Buy Rating - AInvest

Jul 23, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics Breaks Below 200-Day Moving AverageNotable for AXSM - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Axsome Therapeutics Inc. stock priceUnprecedented profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Readystate Asset Management LP Invests $6.95 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s 4th Largest Position - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

ALKS Down Despite Positive Top-Line Data From Narcolepsy Study - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

Mizuho reiterates Outperform rating on Axsome Therapeutics stock By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics: Promising Growth Driven by Robust Pipeline and Strategic Fit - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by New York State Common Retirement Fund - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Lindbrook Capital LLC Sells 14,103 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Axsome Therapeutics Inc. stockExtraordinary market timing - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Axsome Therapeutics Inc. Stock Analysis and ForecastUnstoppable trading performance - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Axsome Therapeutics Rings the Opening Bell - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Axsome Therapeutics hosts frontiers in Brain Health R&D Day - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline - Lelezard

Jul 21, 2025
pulisher
Jul 21, 2025

Axsome Therapeutics: A CNS Pipeline with High-Impact Catalysts for Long-Term Growth - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Axsome Therapeutics Hosts R&D Day to Present Comprehensive Data on CNS Pipeline Targeting Alzheimer’s Disease, Depression, Narcolepsy, Fibromyalgia, ADHD, and Smoking Cessation - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Axsome Reveals New Phase 3 Data for 6 Major Brain Disorders: Expert Panel Discusses Breakthrough Treatments - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

Axsome Celebrates New CNS Drug Launch with NASDAQ Bell Ringing, Unveils Brain Health Pipeline - Stock Titan

Jul 21, 2025
pulisher
Jul 20, 2025

Bank of New York Mellon Corp Has $15.28 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

William Blair Issues Negative Outlook for AXSM Earnings - MarketBeat

Jul 20, 2025
pulisher
Jul 19, 2025

Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Enliven Therapeutics (ELVN) - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

Mizuho reiterates Outperform rating on Axsome Therapeutics stock ahead of R&D Day - Investing.com Australia

Jul 18, 2025
pulisher
Jul 18, 2025

Edgestream Partners L.P. Purchases New Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 18, 2025
pulisher
Jul 15, 2025

Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 4.5% this past week - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Alps Advisors Inc. Has $3.78 Million Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 15, 2025
pulisher
Jul 14, 2025

(AXSM) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 14, 2025
pulisher
Jul 13, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Sold by Iridian Asset Management LLC CT - MarketBeat

Jul 13, 2025
pulisher
Jul 11, 2025

Penserra Capital Management LLC Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 11, 2025
pulisher
Jul 10, 2025

Stocks Showing Improving Market Leadership: Axsome Therapeutics Earns 85 RS Rating - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Morgan Stanley Assumes Coverage of Axsome Therapeutics (AXSM) with an Overweight Rating - MSN

Jul 10, 2025
pulisher
Jul 09, 2025

Axsome Therapeutics (AXSM) Soars 5.77% on Positive Analyst Ratings - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21 - 富途牛牛

Jul 09, 2025
pulisher
Jul 09, 2025

Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4 - The Manila Times

Jul 09, 2025
pulisher
Jul 09, 2025

Axsome Therapeutics Scheduled to Report Q2 2025 Financial Results and Host Conference Call on August 4, 2025 - Nasdaq

Jul 09, 2025
pulisher
Jul 08, 2025

RBC Capital Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM) - The Globe and Mail

Jul 08, 2025
pulisher
Jul 08, 2025

Axsome Therapeutics shares rise 1.08% intraday as RBC Capital Markets maintains its stance on the biopharma company. - AInvest

Jul 08, 2025

Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):